• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Prezista (darunavir) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- June 2009

 

Summary View

 

DRUG INTERACTIONS

  • include results from a drug-drug interaction study between darunavir/ritonavir twice daily and buprenorphine/naloxone
  • Narcotic Analgesic/Treatment of Opioid Dependence: No dose adjustment for buprenorphine or buprenorphine/naloxone is required with concurrent administration of Prezista/rtv. Clinical monitoring is recommended if Prezista/rtv. and buprenorphine or buprenorphine/naloxone are coadministered.

PATIENT PACKAGE INSERT

Can prezista be taken with other Medications?
  • Tell your doctor if your taking any of the following medecines: buprenorphine/naloxone